Overhaul for EU pharma distribution practices
This article was originally published in SRA
Executive Summary
The European Commission has adopted substantial changes to its guideline on good distribution practices (GDPs) for pharmaceutical products to deal with the complex supply chains of the 21st century and to take account of the changes introduced by the EU Falsified Medicines Directive1,2.